ML
McAdam LLC’s Leap Therapeutics LPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-45,778
| Closed | -$15.6K | – | 266 |
|
|
2023
Q1 | $15.6K | Buy |
45,778
+12,994
| +40% | +$4.42K | ﹤0.01% | 251 |
|
|
2022
Q4 | $106K | Sell |
32,784
-14,192
| -30% | -$45.9K | 0.01% | 186 |
|
|
2022
Q3 | $41K | Sell |
46,976
-4,500
| -9% | -$3.93K | ﹤0.01% | 209 |
|
|
2022
Q2 | $59K | Buy |
51,476
+2,591
| +5% | +$2.97K | 0.01% | 211 |
|
|
2022
Q1 | $86K | Buy |
48,885
+16,101
| +49% | +$28.3K | 0.01% | 205 |
|
|
2021
Q4 | $106K | Sell |
32,784
-250
| -0.8% | -$808 | 0.01% | 186 |
|
|
2021
Q3 | $132K | Sell |
33,034
-2,966
| -8% | -$11.9K | 0.01% | 172 |
|
|
2021
Q2 | $51K | Buy |
36,000
+17,613
| +96% | +$25K | 0.01% | 175 |
|
|
2021
Q1 | $35K | Sell |
18,387
-14,610
| -44% | -$27.8K | ﹤0.01% | 160 |
|
|
2020
Q4 | $72K | Buy |
+32,997
| New | +$72K | 0.01% | 160 |
|